Vesalius Biocapital Partners (investor - Private Equity)
See something wrong or missing? Let us know
Offices:Luxembourg
Vesalius Biocapital is a European life sciences venture capital investor, investing later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe.
- in 2023, Vesalius Biocapital announced the first close of its fourth fund at over €95 million.
Average round investment:36.94M USD
Average number per year:2.4
Mostly invests in:
Germany (7)
Health services (19)

See the entire list
Showing 3 of 19 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Vesalius Biocapital Partners mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Vesalius Biocapital Partners
Name | Criteria | |
---|---|---|
![]() |
Tapestry
100%
|
|
![]() |
Pantera Capital
100%
|
|
![]() |
Amundi Asset Management
100%
|
|
![]() |
Endeit Capital
100%
|
|
![]() |
Korys
100%
|
|
![]() |
Re-Pie Asset Management
100%
|
|
![]() |
Yabeo
100%
|
|
![]() |
ABB Technology Ventures (ATV)
100%
|
|
![]() |
Samsung Next
99%
|
|
![]() |
White Star Capital
99%
|
|